MIR503 Gene

HGNC Family Non-coding RNAs
Name microRNA 503
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐503 has emerged as a multifunctional regulatory molecule in both physiological and pathological contexts. In endothelial and differentiating tissues it participates in vascular homeostasis and cell‐cycle control. For example, in pulmonary arterial endothelial cells, decreased miR‐503 (in concert with miR‐424) downstream of apelin deficiency leads to disinhibition of FGF2/FGFR1 signaling and increased endothelial proliferation in pulmonary arterial hypertension."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In skeletal muscle differentiation, induction of miR‐503 (along with miR‐322/424) helps enforce a G1 arrest by post‐transcriptionally downregulating CDC25A, thereby contributing to myoblast differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In bone homeostasis, miR‐503 is markedly reduced in osteoclast progenitors from postmenopausal osteoporosis patients, and its restoration inhibits RANK‐dependent osteoclastogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer, miR‐503 functions in a context‐dependent manner, often exerting tumor‐suppressive actions yet also, in select settings, exhibiting oncogenic features. Several studies indicate that miR‐503 suppresses angiogenesis in hepatocellular and other cancers by coordinately down‐regulating potent angiogenic factors such as FGF2 and VEGFA."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In non‐small cell lung cancer, enforced miR‐503 expression inhibits tumor cell proliferation and metastasis by targeting components of the PI3K/IKK‐β pathway"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", as well as by directly repressing anti‐apoptotic Bcl‐2 to sensitize cells to cisplatin."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In endometrioid endometrial cancer, miR‐503 targets cyclin D1 (CCND1) to impair cell‐cycle progression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ", and similarly in breast cancer, reduced miR‐503 levels correlate with enhanced proliferation by failing to restrain CCND1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In glioblastoma, diminished miR‐503 facilitates oncogenic insulin‐like growth factor‐1 receptor (IGF‐1R) signaling"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", whereas in prostate cancer, restoration of miR‐503 (which is suppressed by reduced GATA3 activity) targets oncogenic factors such as ZNF217"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "and RNF31."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Notably, in colon adenoma progression, cooperative expression of miR‐182 and miR‐503 results in repression of the tumor suppressor FBXW7 and appears to drive malignant transformation"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", while in ovarian cancer the miR‐424/503 cluster suppresses the oncogenic kinesin KIF23 thereby inhibiting cell proliferation and migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Interestingly, divergent roles have been reported in breast cancer as certain studies describe an overexpressed miR‐503‐3p isoform that promotes epithelial–mesenchymal transition by targeting SMAD2 and reducing E‐cadherin"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", highlighting that isoform‐ or context‐specific processing may dictate whether miR‐503 acts as a tumor suppressor or a promoter of metastasis.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, miR‐503 exerts its regulatory functions by targeting an array of mRNAs involved in key cellular processes. Its repertoire of targets includes regulators of cell cycle progression (CDC25A, CCND1, p21), apoptosis (Bcl‐2, PUMA), growth and angiogenesis (FGF2, VEGFA, IGF‐1R), and components of transforming growth factor‐β and NF‐κB signaling (Smad7, Smurf2, as part of the miR‐424/503 cluster)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " miR‐503 levels are subject to regulation by both epigenetic mechanisms, such as hypermethylation of its promoter in non‐small cell lung cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ", and by interactions with competing endogenous RNAs: long noncoding RNAs like miR503HG in hepatocellular carcinoma synergize with miR‐503 to inhibit metastasis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": ", and circular RNAs such as circ‐BANP act as sponges to reduce miR‐503 activity in lung cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " Furthermore, epigenetic and transcriptional regulation of the broader miR‐424/503 cluster has been linked to TGF‐β–mediated cell cycle arrest in mammary epithelial cells"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ", and chemotherapeutic agents (e.g. epirubicin) can modulate the exosomal export of miR‐503 through RNA‐binding proteins."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these studies underscore that miR‐503 is a key post‐transcriptional regulator that modulates cell proliferation, differentiation, apoptosis, angiogenesis, and metastasis in a tissue‐ and context‐dependent manner. Its dysregulation—whether through altered expression, epigenetic silencing, or sequestration by competing RNAs—can contribute to disease states, ranging from vascular dysfunction and impaired myogenesis to various forms of cancer and chemoresistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_fs", "start_ref": "22", "end_ref": "28"}]}, {"type": "t", "text": " This diverse regulatory capacity of miR‐503 not only aids our understanding of its contributions to disease pathogenesis but also highlights its potential as a prognostic biomarker and therapeutic target in multiple pathological states.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jongmin Kim, Yujung Kang, Yoko Kojima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3040"}], "href": "https://doi.org/10.1038/nm.3040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23263626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23263626"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sukumar Sarkar, Bijan K Dey, Anindya Dutta "}, {"type": "b", "children": [{"type": "t", "text": "MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e10-01-0062"}], "href": "https://doi.org/10.1091/mbc.e10-01-0062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20462953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20462953"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Chao Chen, Peng Cheng, Hui Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-503 regulates osteoclastogenesis via targeting RANK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Bone Miner Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbmr.2032"}], "href": "https://doi.org/10.1002/jbmr.2032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23821519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23821519"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bisheng Zhou, Ruihua Ma, Wenxia Si, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2013.01.028"}], "href": "https://doi.org/10.1016/j.canlet.2013.01.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23352645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23352645"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yi Yang, Lei Liu, Ying Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.28799"}], "href": "https://doi.org/10.1002/ijc.28799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24550137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24550137"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Tianzhu Qiu, Li Zhou, Tongshan Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2013.1439"}], "href": "https://doi.org/10.3892/ijmm.2013.1439"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23856992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23856992"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yan-Ying Xu, Hui-Juan Wu, Hong-Da Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.12365"}], "href": "https://doi.org/10.1111/febs.12365"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23731275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23731275"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jianting Long, Caiwen Ou, Haoming Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3623-8"}], "href": "https://doi.org/10.1007/s13277-015-3623-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26047605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26047605"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yingying Zhang, Xiong Chen, Haiwei Lian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2951"}], "href": "https://doi.org/10.3892/or.2013.2951"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24378652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24378652"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jeanette Baran-Gale, Jeremy E Purvis, Praveen Sethupathy "}, {"type": "b", "children": [{"type": "t", "text": "An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1261/rna.056895.116"}], "href": "https://doi.org/10.1261/rna.056895.116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27539783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27539783"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yun Li, Wei Li, Zhe Ying, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metastatic heterogeneity of breast cancer cells is associated with expression of a heterogeneous TGFβ-activating miR424-503 gene cluster."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-14-0389"}], "href": "https://doi.org/10.1158/0008-5472.CAN-14-0389"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25164015"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25164015"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lihua Li, Aaron L Sarver, Rohini Khatri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4407"}], "href": "https://doi.org/10.1002/path.4407"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25269767"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25269767"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Tong Li, Yimin Li, Yaqi Gan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2019.1624112"}], "href": "https://doi.org/10.1080/15384101.2019.1624112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31135262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31135262"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Zitong Zhao, Xinyi Fan, Lanfang Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Genet Genomics (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jgg.2016.10.005"}], "href": "https://doi.org/10.1016/j.jgg.2016.10.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28161325"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28161325"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Qing Xie, Rebecca McGreal, Raven Harris, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of c-Maf and αA-Crystallin in Ocular Lens by Fibroblast Growth Factor Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.705103"}], "href": "https://doi.org/10.1074/jbc.M115.705103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26719333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26719333"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ning Li, Fangfang Zhang, Suyun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.01.103"}], "href": "https://doi.org/10.1016/j.bbrc.2014.01.103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24486548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24486548"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hui Wang, Linhui Liang, Qiongzhu Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.23012"}], "href": "https://doi.org/10.7150/thno.23012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29774077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29774077"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jingquan Han, Guibin Zhao, Xiao Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.06.172"}], "href": "https://doi.org/10.1016/j.bbrc.2018.06.172"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29969631"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29969631"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jennifer Pérez-Boza, Amandine Boeckx, Michele Lion, et al. "}, {"type": "b", "children": [{"type": "t", "text": "hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-019-03425-6"}], "href": "https://doi.org/10.1007/s00018-019-03425-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31894362"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31894362"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Andrea Caporali, Marco Meloni, Christine Völlenkle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.110.952325"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.110.952325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21220732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21220732"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Rui Zhou, Ai-Yu Gong, Dongqing Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histone deacetylases and NF-kB signaling coordinate expression of CX3CL1 in epithelial cells in response to microbial challenge by suppressing miR-424 and miR-503."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0065153"}], "href": "https://doi.org/10.1371/journal.pone.0065153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23724129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23724129"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fenqiang Xiao, Wu Zhang, Liming Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1479-5876-11-195"}], "href": "https://doi.org/10.1186/1479-5876-11-195"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23967867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23967867"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tomoko Hirakawa, Kaei Nasu, Wakana Abe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/dew217"}], "href": "https://doi.org/10.1093/humrep/dew217"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27619772"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27619772"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Bingshou Li, Lin Liu, Xiaoming Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.06.169"}], "href": "https://doi.org/10.1016/j.bbrc.2015.06.169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26163260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26163260"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Z-L Yin, Y-L Wang, S-F Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced expression of miR-503 is associated with poor prognosis in cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26592830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26592830"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Tomofumi Noguchi, Yuji Toiyama, Takahito Kitajima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncology (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000444493"}], "href": "https://doi.org/10.1159/000444493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26999740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26999740"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yi Sun, Li Li, Shigang Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-170585"}], "href": "https://doi.org/10.3233/CBM-170585"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28800319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28800319"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Shun-Wu Chang, Jie Yue, Bao-Chun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26722476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26722476"}]}]}]}
Synonyms MIR-503, MIRN503, HSA-MIR-503
NCBI Gene ID 574506
API
Download Associations
Predicted Functions View MIR503's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR503's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR503's ARCHS4 Predicted Functions.

Functional Associations

MIR503 has 747 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.

Click the + buttons to view associations for MIR503 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR503 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR503 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR503 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR503 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR503 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR503 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR503 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR503 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR503 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR503 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of MIR503 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR503 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR503 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR503 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR503 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR503 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR503 protein from the Wikipathways Pathways 2014 dataset.